Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Apr 12;8(4):e020254.
doi: 10.1136/bmjopen-2017-020254.

Comparison of intravenous versus combined oral and intravenous antimicrobial prophylaxis (COMBINE) for the prevention of surgical site infection in elective colorectal surgery: study protocol for a multicentre, double-blind, randomised controlled clinical trial

Marie Vignaud  1 , Catherine Paugam-Burtz  2 , Matthias Garot  3 , Samir Jaber  4 , Karem Slim  5 , Yves Panis  6 , Jean-Christophe Lucet  7 , Justine Bourdier  8 , Dominique Morand  8 , Bruno Pereira  9 , Emmanuel Futier  1   10 ; COMBINE trial management committee
Affiliations
Randomized Controlled Trial

Comparison of intravenous versus combined oral and intravenous antimicrobial prophylaxis (COMBINE) for the prevention of surgical site infection in elective colorectal surgery: study protocol for a multicentre, double-blind, randomised controlled clinical trial

Marie Vignaud et al. BMJ Open. .

Abstract

Introduction: Surgical site infections (SSIs) account for 30% of all healthcare-associated infections, with reported rates ranging from 8% and 30% after colorectal surgery and are associated with increased morbidity and mortality rates, length of hospital stay and costs in healthcare. Administration of systemic antimicrobial prophylaxis before surgery is recommended to reduce the risk of SSI, but the optimal regimen remains unclear. We aim to evaluate whether a combined oral and intravenous antimicrobial prophylaxis could be more effective to reduce the incidence of SSI after colorectal surgery, as compared with the standard practice of intravenous antimicrobial prophylaxis alone.

Methods and analysis: Comparison of intravenous versus combined oral and intravenous antimicrobial prophylaxis (COMBINE) trial is a randomised, placebo-controlled, parallel, double-blind, multicentre study of 960 patients undergoing elective colorectal surgery. Patients will be randomly allocated in a 1:1 ratio to receive either combined oral and intravenous antimicrobial prophylaxis or intravenous antibiotic prophylaxis alone, stratified by centre, the surgical procedure (laparoscopic or open surgery) and according to the surgical skin antisepsis (chlorexidine-alcohol or povidione-iodine alcoholic solution). The primary endpoint is the rate of SSI by day 30 following surgery, with SSI defined by the criteria developed by the Centers for Disease Control and Prevention. Data will be analysed on the intention-to-treat principle and a per-protocol basis.

Ethics and dissemination: COMBINE trial has been approved by an independent ethics committee for all study centres. Participant recruitment began in May 2016. Results will be published in international peer-reviewed medical journals.

Trial registration number: EudraCT 2015-002559-84; NCT02618720.

Keywords: clinical trials; colorectal surgery.

PubMed Disclaimer

Conflict of interest statement

Competing interests: EF reports personal fees from Drager, personal fees from Edwards Lifesciences, personal fees from General Electric Healthcare, personal fees from Fresenius Kabi, personal fees from Fisher and Paykel Healthcare, outside the submitted work.

Figures

Figure 1
Figure 1
Flow diagram of the COMBINE trial. IV, intravenous.
See this image and copyright information in PMC

References

    1. Bratzler DW. The surgical infection prevention and surgical care improvement projects: promises and pitfalls. Am Surg 2006;72:1010–6. discussion 21-30, 133-48. - PubMed
    1. Magill SS, Hellinger W, Cohen J, et al. Prevalence of healthcare-associated infections in acute care hospitals in Jacksonville, Florida. Infect Control Hosp Epidemiol 2012;33:283–91. 10.1086/664048 - DOI - PMC - PubMed
    1. Hübner M, Diana M, Zanetti G, et al. Surgical site infections in colon surgery: the patient, the procedure, the hospital, and the surgeon. Arch Surg 2011;146:1240–5. 10.1001/archsurg.2011.176 - DOI - PubMed
    1. Keenan JE, Speicher PJ, Thacker JK, et al. The preventive surgical site infection bundle in colorectal surgery: an effective approach to surgical site infection reduction and health care cost savings. JAMA Surg 2014;149:1045–52. 10.1001/jamasurg.2014.346 - DOI - PubMed
    1. Aimaq R, Akopian G, Kaufman HS. Surgical site infection rates in laparoscopic versus open colorectal surgery. Am Surg 2011;77:1290–4. - PubMed

Publication types

Associated data

LinkOut - more resources